A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
CRISPR-Cas9 筛选 AHR 诱导 CYP1A1 所需的新型蛋白质
基本信息
- 批准号:9276681
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:ARNT proteinAdverse effectsAffectAgonistAllelesAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorBase SequenceBenzo(a)pyreneBindingCRISPR libraryCRISPR screenCRISPR/Cas technologyCYP1A1 geneCYP1A2 geneCYP1B1 geneCarcinogensCell LineCell NucleusCellsChemicalsChromatin StructureCodeCultured CellsDNA Double Strand BreakDimerizationDioxinsDiploid CellsEnhancersEnvironmental PollutantsExhibitsFamily memberFoundationsFrameshift MutationFrequenciesFutureGene ExpressionGenerationsGenesGenetic TranscriptionGenomicsGoalsGuide RNAHypoxiaHypoxia Inducible FactorKnockout MiceLeadLentivirus VectorLibrariesLigandsMammalian CellMammalsMediatingMessenger RNAMicroRNAsMusPlayPolychlorinated BiphenylsProteinsRNA Polymerase IIRecruitment ActivityResistanceRoleSmogSystemTestingTetrachlorodibenzodioxinTissuesTobacco smokeToxic effectTranscriptional ActivationValidationVariantaryl hydrocarbon receptor ligandcarcinogenesiscarcinogenicitycellular transductioncytotoxicdibenzofurandimergene inductiongene producthepatoma cellin vivointerestloss of functionmutantnovelpreventpromoterpublic health relevancereceptor bindingresponsescreeningtumor growthtumor progressionvector
项目摘要
DESCRIPTION (provided by applicant): The environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has a large number of toxic effects, including carcinogenicity. All the toxic effects of TCDD and of related polychlorinated compounds are mediated by the Aryl Hydrocarbon Receptor (AHR) and depend upon transcriptional activation by the AHR of not yet fully identified downstream genes. AHR also mediates carcinogenesis by polycyclic aromatic hydrocarbons, (e.g. benzo[a]pyrene) which are important carcinogens in tobacco smoke and smog. CYP1A1, CYP1A2 and CYP1B1 are massively induced in many tissues and are likely responsible for mediating the carcinogenic effects of PAHs, via metabolizing them to electrophilic derivatives. After binding agonist, the AHR translocates to the nucleus and forms a dimer with the aryl hydrocarbon nuclear translocator (ARNT) protein, which then binds to the enhancer regions of responsive genes, thereby leading to their transcriptional activation. In the current proposal we will seek to identify novel gene products that play roles in
the induction of gene transcription by AHR, by screening a CRISPR-Cas9 library. The CRISPR-Cas9 system can induce DNA double strand breaks at specific genomic loci through synthetic 20 nucleotide sequences within guide RNAs (gRNAs), which when targeted to coding regions of genes can generation of deletions or insertions, resulting in frameshift mutations which lead to loss of function at both alleles in a diploid cell. There are two specific aims. In Specific Aim 1,
genes required for CYP1A1 induction will be identified by using the GeCKOv2 library, which targets 20,611 mouse genes (and thus nearly all protein coding genes) and also 1,178 microRNAs. The library is contained in a single high titer lentiviral vector (lentiCRISPRv2), which
will be transduced into the mouse hepatoma cell line, Hepa-1. The transduced cells will be selected for 10 days in benzo[a]pyrene. (Benzo[a]pyrene-resistant clones exhibit loss of AHR-dependent induction of CYP1A1). PCR amplification of the integrated gRNAs and their sequencing will then be performed. Those genes represented by more than one gRNA, and/or identified in more than one transduced culture, and/or represented at high frequency, are likely to represent true positives. Specific Aim 2 will validate hits from the screen. Two gRNAs for each gene of interest will be inserted into lentiCRISPRv2 to determine if they confer benzo[a]pyrene resistance, reduce TCDD induction of CYP1A1, and reduce AHR and ARNT expression upon transduction into Hepa-1 cells. The corresponding endogenous genes will be sequenced in certain transductants to see if they contain deletions or insertions. Characterization of confirmed hits will be pursued in a future R01 application. Such hits may include gene products that affect AHR or ARNT expression or function, and/or that are required for transcriptional activation of CYP1A1. The current proposal therefore lays the foundations for a comprehensive analysis of the mechanism of AHR-dependent induction of gene transcription, and may lead to strategies for reducing the harmful effects of ligands of the AHR.
描述(申请人提供):环境污染物2,3,7,8-四氯二苯并-对二恶英(TCDD)具有大量毒性作用,包括致癌性。 TCDD 和相关多氯化合物的所有毒性作用均由芳基烃受体 (AHR) 介导,并取决于 AHR 对尚未完全鉴定的下游基因的转录激活。 AHR 还介导多环芳烃(例如苯并[a]芘)的致癌作用,多环芳烃是烟草烟雾和烟雾中的重要致癌物。 CYP1A1、CYP1A2 和 CYP1B1 在许多组织中被大量诱导,并且可能通过将 PAH 代谢为亲电子衍生物来介导 PAH 的致癌作用。与激动剂结合后,AHR易位到细胞核并与芳基烃核易位蛋白(ARNT)形成二聚体,然后与反应基因的增强子区域结合,从而导致其转录激活。在当前的提案中,我们将寻求识别在以下方面发挥作用的新型基因产物:
通过筛选 CRISPR-Cas9 文库,AHR 诱导基因转录。 CRISPR-Cas9系统可以通过引导RNA(gRNA)内合成的20个核苷酸序列在特定基因组位点诱导DNA双链断裂,当靶向基因的编码区域时,可以产生缺失或插入,从而导致移码突变,导致二倍体细胞中两个等位基因的功能丧失。有两个具体目标。在具体目标 1 中,
CYP1A1 诱导所需的基因将通过使用 GeCKOv2 文库进行鉴定,该文库针对 20,611 个小鼠基因(以及几乎所有蛋白质编码基因)和 1,178 个 microRNA。该文库包含在单个高效价慢病毒载体 (lentiCRISPRv2) 中,
将被转导至小鼠肝癌细胞系 Hepa-1 中。转导的细胞将在苯并[a]芘中选择10天。 (苯并[a]芘抗性克隆表现出 AHR 依赖性 CYP1A1 诱导的丧失)。然后对整合的 gRNA 进行 PCR 扩增及其测序。由超过一种 gRNA 代表的、和/或在超过一种转导的培养物中鉴定出的、和/或以高频率代表的那些基因可能代表真阳性。特定目标 2 将验证屏幕上的命中。每个感兴趣基因的两个 gRNA 将被插入 lentiCRISPRv2 中,以确定它们是否赋予苯并[a]芘抗性,减少 CYP1A1 的 TCDD 诱导,并在转导到 Hepa-1 细胞后减少 AHR 和 ARNT 表达。将在某些转导子中对相应的内源基因进行测序,以查看它们是否包含缺失或插入。已确认命中的特征将在未来的 R01 应用中进行。此类命中可能包括影响 AHR 或 ARNT 表达或功能和/或 CYP1A1 转录激活所需的基因产物。因此,当前的提议为全面分析 AHR 依赖性基因转录诱导机制奠定了基础,并可能导致减少 AHR 配体有害影响的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OLIVER nmn HANKINSON其他文献
OLIVER nmn HANKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OLIVER nmn HANKINSON', 18)}}的其他基金
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
CRISPR-Cas9 筛选 AHR 诱导 CYP1A1 所需的新型蛋白质
- 批准号:
9112338 - 财政年份:2016
- 资助金额:
$ 23.1万 - 项目类别:
Function and Regulation of Human Cytochrome P4502S1
人细胞色素P4502S1的功能和调控
- 批准号:
7811735 - 财政年份:2009
- 资助金额:
$ 23.1万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




